基于乳腺癌的精准治疗的靶向药物作用机制相关研究 与卫生经济学思考

秦 　祎¹, 廖 艺涵², 刘 振雨², 王 梓晗³
1、赤峰市肿瘤医院
2、白俄罗斯国立大学萨哈罗夫研究所
3、澳门科技大学中医药学院

摘要

乳腺癌时发生在乳腺部位的恶性肿瘤，我们基于当前的诊疗指南进行了研究，并且对常用的乳腺癌的精准
治疗的要的作用机制进行了叙述，并且以免疫治疗为例以中国为基准进行了相关药物的市场分析与卫生经济学讨论，
目的是大数据统计的辅助下，提出对临床具备指导性的建议。

关键词

乳腺癌；精准治疗；靶向药物；医学研究；卫生经济学

参考

[1]Daemen, A., Griffith, O. L., Heiser, L. M., Wang, N. J.,

Enache, O. M., Sanborn, Z., ... & Gray, J. W. (2013). Modeling

precision treatment of breast cancer. Genome biology, 14(10),

1-14.

[2]Duffy, M. J., O'Donovan, N., McDermott, E., & Crown,

J. (2016). Validated biomarkers: The key to precision treatment

in patients with breast cancer. The Breast, 29, 192-201.

[3]Zhao, S., Zuo, W. J., Shao, Z. M., & Jiang, Y. Z. (2020).

Molecular subtypes and precision treatment of triple-negative

breast cancer. Annals of translational medicine, 8(7).

[4]Yu, S., Cai, X., Wu, C., Liu, Y., Zhang, J., Gong, X.,

... & Chen, L. (2017). Targeting HSP90-HDAC6 regulating

network implicates precision treatment of breast cancer.

International journal of biological sciences, 13(4), 505.

[5]Daemen, Anneleen, et al. “Erratum to: Modeling

precision treatment of breast cancer.” Genome biology 16.1

(2015): 1-3.

[6]Zhang, Y., Zhang, D., Meng, Q., Liu, Z., Xie, H., Liu,

L., ... & Chen, X. (2021). Precision treatment exploration of

breast cancer based on heterogeneity analysis of lncRNAs at

the single-cell level. BMC cancer, 21(1), 1-15.

[7]Arnedos, M., Vicier, C., Loi, S., Lefebvre, C., Michiels,

S., Bonnefoi, H., & Andre, F. (2015). Precision medicine for

metastatic breast cancer— limitations and solutions. Nature

reviews Clinical oncology, 12(12), 693-704.

[8]Blucher, Aurora S., Gordon B. Mills, and Yiu Huen

Tsang. “Precision oncology for breast cancer through clinical

trials.” Clinical & Experimental Metastasis (2021): 1-8.

[9]Carels, N., Spinassé, L. B., Tilli, T. M., & Tuszynski,

J. A. (2016). Toward precision medicine of breast cancer.

Theoretical Biology and Medical Modelling, 13(1), 1-46.

[10]Naito Y, Urasaki T. Precision medicine in breast

cancer[J]. Chin Clin Oncol, 2018, 7(3): 29.

[11]Schwartz, Anna L., et al. “Exercise reduces daily

fatigue in women with breast cancer receiving chemotherapy.”

Medicine & Science in Sports & Exercise 33.5 (2001): 718-

723.

[12]Rouzier, R., Perou, C. M., Symmans, W. F., Ibrahim,

N., Cristofanilli, M., Anderson, K., ... & Pusztai, L. (2005).

Breast cancer molecular subtypes respond differently to

preoperative chemotherapy. Clinical cancer research, 11(16),

5678-5685.

[13]Harbeck, N., Penault-Llorca, F., Cortes, J., Gnant, M.,

Houssami, N., Poortmans, P., ... & Cardoso, F. (2019). Breast

cancer. Nature reviews Disease primers, 5(1), 1-31.

[14]Arribas, J., Baselga, J., Pedersen, K., & Parra-Palau,

J. L. (2011). p95HER2 and breast cancer. Cancer research,

71(5), 1515-1519.